-
Je něco špatně v tomto záznamu ?
Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center
M. Mindlova, P. Boucek, F. Saudek, J. Skibova, T. Jedinakova, K. Lipar, M. Adamec, HH. Hirsch
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Medline Complete (EBSCOhost)
od 1999-01-01 do Před 1 rokem
Wiley Online Library (archiv)
od 1999-01-01 do 2012-12-31
- MeSH
- DNA virů krev MeSH
- dospělí MeSH
- infekce onkogenními viry diagnóza MeSH
- kvantitativní polymerázová řetězová reakce MeSH
- lidé středního věku MeSH
- lidé MeSH
- nemoci ledvin diagnóza etiologie MeSH
- polyomavirové infekce diagnóza MeSH
- replikace viru MeSH
- rizikové faktory MeSH
- transplantace ledvin škodlivé účinky MeSH
- transplantace slinivky břišní škodlivé účinky MeSH
- viremie diagnóza MeSH
- virová nálož MeSH
- virus BK izolace a purifikace fyziologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: BK virus (BKV) replication is considered as a marker of risk for polyomavirus BK-associated nephropathy (PVAN). We evaluated the occurrence and risk factors for BKV DNA positivity following simultaneous pancreas/kidney transplantation (SPK). METHODS: Point prevalence of BK viruria and viremia was assessed in 183 SPK recipients. Real-time polymerase chain reaction was used with a detection threshold of 10(3) copies/mL. High-level BKV positivity was defined as viruria and/or viremia >10(7) and >10(4) copies/mL, respectively. BKV-positive patients were retested after 4-13 months and underwent an additional six-month clinical follow-up. RESULTS: Urine and serum BKV positivity was detected in 28 (17.3% of available samples) and 7 (3.8%) patients, with high-level viruria and viremia occurring in 6 (3.7%) and 3 (1.6%) patients, respectively. PVAN was biopsy-confirmed in 1 and suspected as a cause of progressive renal failure in another SPK recipient. Patients with single low-level viruria did not progress to high-level positivity or PVAN at follow-up. In multivariate analysis, pre-transplant diabetes duration and delayed graft function were independently associated with BKV positivity. CONCLUSIONS: Point prevalence of high-level BKV positivity and PVAN was low in SPK recipients from a single center. Diabetes duration and delayed graft function were independent risk factors for BKV replication.
Department of Transplantation Virology Institute for Medical Microbiology
Diabetes Center Institute for Clinical and Experimental Medicine
Diabetes Center Institute for Clinical and Experimental Medicine Prague Czech Republic
Division of Infectious Diseases Universitätsspital Basel Basel Switzerland
Transplant Center Institute for Clinical and Experimental Medicine Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034913
- 003
- CZ-PrNML
- 005
- 20210421142711.0
- 007
- ta
- 008
- 121023s2012 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1399-0012.2011.01488.x $2 doi
- 035 __
- $a (PubMed)21854452
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Mindlová, Martina $7 xx0092588 $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 245 10
- $a Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center / $c M. Mindlova, P. Boucek, F. Saudek, J. Skibova, T. Jedinakova, K. Lipar, M. Adamec, HH. Hirsch
- 520 9_
- $a BACKGROUND: BK virus (BKV) replication is considered as a marker of risk for polyomavirus BK-associated nephropathy (PVAN). We evaluated the occurrence and risk factors for BKV DNA positivity following simultaneous pancreas/kidney transplantation (SPK). METHODS: Point prevalence of BK viruria and viremia was assessed in 183 SPK recipients. Real-time polymerase chain reaction was used with a detection threshold of 10(3) copies/mL. High-level BKV positivity was defined as viruria and/or viremia >10(7) and >10(4) copies/mL, respectively. BKV-positive patients were retested after 4-13 months and underwent an additional six-month clinical follow-up. RESULTS: Urine and serum BKV positivity was detected in 28 (17.3% of available samples) and 7 (3.8%) patients, with high-level viruria and viremia occurring in 6 (3.7%) and 3 (1.6%) patients, respectively. PVAN was biopsy-confirmed in 1 and suspected as a cause of progressive renal failure in another SPK recipient. Patients with single low-level viruria did not progress to high-level positivity or PVAN at follow-up. In multivariate analysis, pre-transplant diabetes duration and delayed graft function were independently associated with BKV positivity. CONCLUSIONS: Point prevalence of high-level BKV positivity and PVAN was low in SPK recipients from a single center. Diabetes duration and delayed graft function were independent risk factors for BKV replication.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a virus BK $x izolace a purifikace $x fyziologie $7 D001739
- 650 _2
- $a DNA virů $x krev $7 D004279
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nemoci ledvin $x diagnóza $x etiologie $7 D007674
- 650 _2
- $a transplantace ledvin $x škodlivé účinky $7 D016030
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a transplantace slinivky břišní $x škodlivé účinky $7 D016035
- 650 _2
- $a polyomavirové infekce $x diagnóza $7 D027601
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a infekce onkogenními viry $x diagnóza $7 D014412
- 650 _2
- $a virová nálož $7 D019562
- 650 _2
- $a viremie $x diagnóza $7 D014766
- 650 _2
- $a replikace viru $7 D014779
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bouček, Petr, $d 1955-2015 $7 nlk20010095502 $u Diabetes Center, Institute for Clinical and Experimental Medicine
- 700 1_
- $a Saudek, František, $d 1955- $7 nlk20000083698 $u Diabetes Center, Institute for Clinical and Experimental Medicine
- 700 1_
- $a Skibová, Jelena $7 xx0061183 $u Diabetes Center, Institute for Clinical and Experimental Medicine; Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Jedináková, Teodora, $d 1975- $7 xx0062088 $u Diabetes Center, Institute for Clinical and Experimental Medicine
- 700 1_
- $a Lipár, Květoslav $7 xx0231456 $u Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Adamec, Miloš, $d 1959- $7 nlk20000083689 $u Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Hirsch, Hans H. $u Department of Transplantation Virology, Institute for Medical Microbiology; Division of Infectious Diseases, Universitätsspital Basel, Basel, Switzerland
- 773 0_
- $w MED00001167 $t Clinical transplantation $x 1399-0012 $g Roč. 26, č. 2 (2012), s. 267-274
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21854452 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20210421142708 $b ABA008
- 999 __
- $a ok $b bmc $g 956923 $s 792410
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 26 $c 2 $d 267-274 $e 20110821 $i 1399-0012 $m Clinical transplantation $n Clin Transplant $x MED00001167
- LZP __
- $b NLK112 $a Pubmed-20121023